Fixed‐dose combination therapy for the prevention of atherosclerotic cardiovascular diseases

BACKGROUND: Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death and disability worldwide, yet ASCVD risk factor control and secondary prevention rates remain low. A fixed‐dose combination of blood pressure‐ and cholesterol‐lowering and antiplatelet treatments into a single p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cochrane Database Syst Rev
Autors principals: Bahiru, Ehete, de Cates, Angharad N, Farr, Matthew RB, Jarvis, Morag C, Palla, Mohan, Rees, Karen, Ebrahim, Shah, Huffman, Mark D
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Ltd 2017
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6464321/
https://ncbi.nlm.nih.gov/pubmed/28263370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD009868.pub3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars